欧洲多中心分析:早期肺腺癌伴侵袭性病理特征患者肺叶切除与肺段切除的比较
该回顾性多中心队列研究纳入2015至2021年10个欧洲中心1703例cT1a-bN0M0肺腺癌患者,其中530例至少有一种不良病理特征。结论提示对怀疑有不良病理特征的IA1-2期肺腺癌,肺段切除加系统淋巴结清扫可考虑。
要点
- 早期肺腺癌伴不良病理特征者,肺段切除与肺叶切除的5年生存相似。
- 肺段切除加系统淋巴结清扫可作为IA1-2期伴不良特征患者的指征。
核心结论
- 对怀疑有不良病理特征的IA1-2期肺腺癌,肺段切除加系统淋巴结清扫可考虑。
- 多重不良病理特征影响总生存,但无法通过临床病理特征预测。
研究设计与样本
- 回顾性多中心队列研究,纳入2015至2021年10个欧洲中心1703例cT1a-bN0M0肺腺癌患者。
- 530例至少有一种不良病理特征,130例有多种特征,比较肺叶切除与肺段切除(均行系统淋巴结清扫)。
主要发现
- 匹配队列结果相似。
关键数值与推荐
- 不良病理特征包括:脏层胸膜侵犯(PL1或PL2)、脉管侵犯、气腔播散、坏死或神经侵犯。
临床怎么用
- 对IA1-2期肺腺癌怀疑有不良病理特征者,可考虑肺段切除加系统淋巴结清扫。
- 多重不良特征患者总生存较差,需加强术后随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the impact of common pathologic features, single or in combination, in patients with early-stage lung adenocarcinoma, according to lung resection extent. METHODS: A retrospective, multicentric cohort study including patients with cT1a-bN0M0 lung adenocarcinoma and with at least visceral pleural invasion under the surface (PL1) or up to surface (PL2), lymphovascular invasion, spread through air spaces, necrosis, or neural invasion who underwent lobectomy or segmentectomy with systematic lymph nodal dissection from 2015 to 2021 in 10 European centers. Overall survival (OS), disease-free survival, and lung cancer-specific death between both groups were assessed before and after stabilized inverse probability of treatment-weighting matching. Risk factors for oncologic outcomes were analyzed using parsimonious model Cox proportional hazard regression in both entire and multiple-feature datasets. Kaplan-Meier and cumulative incidence function was used to assess outcome. Log-rank and Gray tests were used to compare the groups. Linearized risk assessed recurrences. RESULTS: Of 1703 patients with cT1a-bN0M0 lung adenocarcinoma, 530 had at least 1 poor pathologic feature and 130 had multiple features. For the 530 patients, 5-year OS: lobectomy was 83.0% and segmentectomy was 89.4%, P = .2; 5-year disease-free survivall obectomy was 78.1% segmentectomy was 83.8%, P = .06; and 5-year lung cancer-specific death lobectomy was 8.9% and segmentectomy was 7.2%, P = .6, which were similar. It was the same in the matched cohort. In multivariable analysis, no poor pathologic feature impacted outcome more than others. Multiple poor features were not associated with any clinical, pathologic trait, but they impacted OS (hazard ratio, 3.24; P = .002). Locoregional recurrence (linearized risk: lobectomy 0.083, segmentectomy 0.086) was similar in the matched entire dataset. CONCLUSIONS: Segmentectomy with systematic lymph nodal dissection can be indicated in patients with stage IA1-2 lung adenocarcinoma suspected to have poor pathologic features. Multiple factors were not predictable but impacted OS.
引用
- Lula LJ, Costa R, Franssen AJPM, et al. European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy. J Thorac Cardiovasc Surg. 2026. PMID: 42086164. doi:10.1016/j.jtcvs.2026.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。